In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

NCT01132417 · clinicaltrials.gov ↗

SUSPENDED

Status

500

Enrollment

OTHER

Sponsor class

Stopped researchers delay

Conditions

Infections, Bacterial

Interventions

DRUG: In Vitro activity of Tigecycline among key bacterial pathogens exhibiting multidrug resistance

Sponsor

King Faisal University